Rapid Selection of High-Affinity Antibody scFv Fragments Using Ribosome Display
- PMID: 30196501
- DOI: 10.1007/978-1-4939-8648-4_13
Rapid Selection of High-Affinity Antibody scFv Fragments Using Ribosome Display
Abstract
Ribosome display has proven to be a powerful in vitro selection and evolution method for generating high-affinity binders from libraries of folded proteins. It works entirely in vitro, and this has two important consequences. First, since no transformation of any cells is required, libraries with much greater diversity can be handled than with most other techniques. Second, since a library does not have to be cloned and transformed, it is very convenient to introduce random errors in the library by PCR-based methods and select improved binders. Thus, a true directed evolution, an iteration between randomization and selection over several generations, can be conveniently carried out, e.g., for affinity maturation, either on a given clone or on the whole library. Ribosome display has been successfully applied to antibody single-chain Fv fragments (scFv), which can be selected not only for specificity but also for stability and catalytic activity. High-affinity binders with new target specificity can be obtained from highly diverse libraries in only a few selection rounds. In this protocol, the selection from the library and the process of affinity maturation and off-rate selection are explained in detail.
Keywords: Affinity maturation; Antibody scFv fragments; In vitro selection; In vitro translation; Ribosome display.
Similar articles
-
Ribosome display: a technology for selecting and evolving proteins from large libraries.Methods Mol Biol. 2011;687:283-306. doi: 10.1007/978-1-60761-944-4_21. Methods Mol Biol. 2011. PMID: 20967617
-
Rapid selection of high-affinity binders using ribosome display.Methods Mol Biol. 2012;805:261-86. doi: 10.1007/978-1-61779-379-0_15. Methods Mol Biol. 2012. PMID: 22094811
-
Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries.Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14130-5. doi: 10.1073/pnas.95.24.14130. Proc Natl Acad Sci U S A. 1998. PMID: 9826665 Free PMC article.
-
Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics.J Immunol Methods. 2001 Feb 1;248(1-2):31-45. doi: 10.1016/s0022-1759(00)00341-0. J Immunol Methods. 2001. PMID: 11223067 Review.
-
In vitro display technologies: novel developments and applications.Curr Opin Biotechnol. 2001 Aug;12(4):400-5. doi: 10.1016/s0958-1669(00)00234-2. Curr Opin Biotechnol. 2001. PMID: 11551470 Review.
Cited by
-
The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics.J Immunol Res. 2024 Aug 9;2024:1804038. doi: 10.1155/2024/1804038. eCollection 2024. J Immunol Res. 2024. PMID: 39156005 Free PMC article. Review.
-
Molecular Dynamics Simulations in Designing DARPins as Phosphorylation-Specific Protein Binders of ERK2.Molecules. 2021 Jul 27;26(15):4540. doi: 10.3390/molecules26154540. Molecules. 2021. PMID: 34361694 Free PMC article.
-
Cell-Free Approach for Non-canonical Amino Acids Incorporation Into Polypeptides.Front Bioeng Biotechnol. 2020 Sep 28;8:1031. doi: 10.3389/fbioe.2020.01031. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33117774 Free PMC article.
-
mRNA Display Pipeline for Protein Biosensor Construction.ACS Sens. 2024 Jun 28;9(6):2846-2857. doi: 10.1021/acssensors.3c02471. Epub 2024 May 29. ACS Sens. 2024. PMID: 38807313 Free PMC article.
-
Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging.Biomedicines. 2023 Jul 24;11(7):2086. doi: 10.3390/biomedicines11072086. Biomedicines. 2023. PMID: 37509725 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources